動物保健市場——按產品[藥品、醫療器械、服務]、按動物、分銷——到 2032 年的全球預測
市場調查報告書
商品編碼
1260669

動物保健市場——按產品[藥品、醫療器械、服務]、按動物、分銷——到 2032 年的全球預測

Animal Healthcare Market - By Product [Pharmaceuticals, Medical Device, Service], Animal, Distribution - Global Forecast to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 306 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於動物福利和寵物健康方面的支出增加,預計到 2032 年動物保健市場將呈指數級增長。

此外,寵物美容、鍛煉、散步、訓練、寄宿、寵物看護和庭院工作等寵物服務支出的增加預計也將在擴大市場方面發揮重要作用。 此外,對獸藥預防疾病和提供優質護理的需求不斷增長,也將加速市場擴張。

隨著新興經濟體難以維持基本的人力資源、財務和實施計劃,預計未來幾年行業增長將停滯不前。 此外,動物保健是一個被忽視的領域,這可能會對未來的市場前景產生不利影響。 然而,人們對人畜共患疾病的認識不斷提高,以及支持在線藥店的電子商務平台的出現,將進一步推動未來幾年的市場增長。

總體而言,動物保健市場按產品、動物、分銷渠道和地區進行細分。

按產品劃分,由於對獸醫服務的需求不斷增長,預計到 2022 年獸醫保健服務的市場份額將超過 755 億美元,並且到 2032 年將顯著增長。 此外,發達國家日益增加的動物健康問題和生活方式的改變將進一步增加對獸醫醫療服務的偏好,這將推動業務增長。

按動物分類,由於寵物擁有量增加、獸藥支出增加以及對優質寵物產品的需求增加,預計到 2032 年底伴侶動物市場將出現顯著增長。 此外,移動寵物美容服務、寵物和寵物保險等醫療保健設施創新的增加,也將在預測期內支持該細分市場的增長。

由於動物護理產品種類繁多且價格相對較低,預計經銷商將呈指數級增長。 而且代理服務的客戶數量多,所以是雙贏的。 商家可以利用規模經濟,客戶也可以享受折扣價。 批發價格和種類繁多的產品有望在未來促進該細分市場的擴張。

按地區劃分,預計 2022 年北美動物保健市場的收入份額將超過 39%,在預測期內呈現顯著增長。 該地區的市場擴張歸因於可支配收入增加推動寵物健康支出增加,以及針對易患慢性病的牲畜和伴侶動物的個性化寵物護理的進步。這是有可能的。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章動物保健行業洞察

  • 按行業細分
  • 行業格局,2018-2032 年版
  • 行業影響因子
    • 司機
      • 增加寵物的陪伴
      • 加強政府和公共機構對動物福利的支持
      • 對動物在線藥店的需求不斷擴大
      • 動物保健費用增加
    • 行業潛在的風險和挑戰
      • 與動物保健藥物相關的高成本
      • 新興國家/地區在寵物保健方面的支出較低
  • 增長分析
    • 按產品分類
    • 按動物類型
    • 按分銷渠道
  • COVID-19 影響分析
  • 監管狀況
    • 美國
    • 歐洲
    • 亞太地區
  • 技術概況
  • 退款場景
  • 動物保健行業的風險資本家場景
  • 政策和情況
  • 差距分析
  • 消費者行為趨勢
  • 行業生態系統
  • 波特分析
  • 2021 年競爭格局
    • 2021 年公司矩陣分析
  • PESTEL 分析

第 4 章競爭格局,2021 年

  • 介紹
  • 2021 年公司矩陣分析
  • 戰略儀表板,2021 年

第 5 章動物保健市場:按產品分類

  • 主要細分趨勢
  • 醫藥
    • 藥物
      • 抗癱劑
      • 抗炎作用
      • 抗感染藥
      • 其他
    • 疫苗
      • 改良活疫苗 (MLV)
      • 滅活□□疫苗
      • 其他
    • 藥用飼料添加劑
      • 抗生素
      • 維生素
      • 抗氧化劑
      • 益生元和益生菌
      • 礦物質
      • 其他
  • 醫療設備
    • 獸醫診斷設備
    • 獸醫麻醉設備
    • 動物監測設備
    • 獸醫手術器械
    • 動物消耗品
    • 其他
  • 獸醫服務
  • 醫療設備
  • 獸醫服務

第 6 章動物保健市場:動物類型

  • 主要細分趨勢
  • 家畜
    • 家禽
    • 斯溫
    • 奶牛
    • 其他
  • 伴侶動物
    • 馬肉
    • 其他

第 7 章動物保健品市場:按分銷渠道

  • 主要細分趨勢
  • 藥店
  • 電子商務
  • 分銷商

第 8 章動物保健市場:區域細分

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 波蘭
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 台灣
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 海灣合作委員會國家
    • 以色列

第九章公司簡介

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals
  • Elanco Animal Health
  • Merck & Co
  • Symrise
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.
  • Medtronic plc
  • IDEXX Laboratories
  • HIPRA
  • Endovac Animal Health
  • B. Braun Vet Care(B Braun Melsungen AG)
  • Sklar Surgical Instruments
  • Neogen Corporation
簡介目錄
Product Code: 735

Animal Healthcare Market is slated to grow exponentially through 2032, owing to the rising expenditure on animal welfare and pet health. Furthermore, increasing spending on pet services such as grooming, exercise, walking, training, boarding, pet sitting, and yard service will also play a key role in market expansion. In addition, the growing need for animal medicines to prevent diseases and offer quality treatment to animals is further slated to escalate the market progression.

The industry is anticipated to witness stagnant growth in the coming years, as developing countries struggle to maintain basic human facilities, raise funds, and organize several programs. Besides, animal healthcare is a neglected sector, which may also negatively influence the market outlook in the future. However, the increasing awareness regarding zoonotic illnesses and the mounting presence of e-commerce platforms supporting online pharmacies will further drive market growth in the coming years.

Overall, the animal healthcare market is segmented in terms of product, animal, distribution channel, and region.

Considering the product, the veterinary services segment held over USD 75.5 billion market share in 2022 and is anticipated to grow considerably through 2032, owing to the rising demand for veterinary services. In addition, the increasing prevalence of health issues in animals and changing lifestyles in developed countries will further increase the preference for veterinary services, thereby boosting business growth.

Based on animals, the companion animal segment is slated to witness massive growth by 2032 end, owing to the increasing adoption of pets, rising expenditure on veterinary care, and growing demand for premium pet products. Besides, ongoing innovations in medical facilities for mobile pet grooming services, pets, and pet insurance will support the segmental growth over the forecast period.

By distribution channel, the distributors segment is slated to grow exponentially owing to the availability of a wide variety of animal care products and comparatively lower pricing. Besides, distributors serve large groups of customers, which is advantageous for both parties. It allows the distributor to use economies of scale, while the customer receives the goods at a discounted price. Wholesale pricing and presence of wide variety of product alternatives are further slated to drive segmental expansion in the future.

Regionally, the North America animal healthcare market held over 39% revenue share in 2022 and is likely to demonstrate massive growth during the forecast period. The regional market expansion can be attributed to the increased expenditure in pet health empowered by high disposable income and advancements in personalized pet medicine for livestock & companion animals that are susceptible to chronic illness.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Methodology
  • 1.2 Market scope & definitions
  • 1.3 Base estimates & working
    • 1.3.1 North America
    • 1.3.2 Europe
    • 1.3.3 Asia Pacific
    • 1.3.4 Latin America
    • 1.3.5 MEA
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data animal types
    • 1.6.1 Secondary
      • 1.6.1.1 Paid animal types
      • 1.6.1.2 Unpaid animal types
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Animal healthcare industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Product trends
    • 2.1.3 Animal type trends
    • 2.1.4 Distribution channel trends
    • 2.1.5 Regional trends

Chapter 3 Animal Healthcare Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing pet adoption for companionship
      • 3.3.1.2 Increasing support offered by government and public organizations for animal care
      • 3.3.1.3 Growing demand for online veterinary pharmacies
      • 3.3.1.4 Increase in animal healthcare expenditure
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High cost associated with animal healthcare drugs
      • 3.3.2.2 Low out of pocket expenditure on pet healthcare in developing countries
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By animal type
    • 3.4.3 By distribution channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
    • 3.6.1 U.S.
    • 3.6.2 Europe
    • 3.6.3 Asia Pacific
  • 3.7 Technology landscape
  • 3.8 Reimbursement scenario
  • 3.9 Venture capitalist scenario in the animal healthcare industry
  • 3.10 Policy landscape
  • 3.11 Gap analysis
  • 3.12 Consumer behaviour trends
  • 3.13 Industry ecosystem
  • 3.14 Porter's analysis
    • 3.14.1 Industry rivalry
    • 3.14.2 Bargaining power of suppliers
    • 3.14.3 Bargaining power of buyers
    • 3.14.4 Threat of substitute
    • 3.14.5 Threat of new entrants
  • 3.15 Competitive landscape, 2021
    • 3.15.1 Company matrix analysis, 2021
  • 3.16 PESTEL analysis
    • 3.16.1 Political
    • 3.16.2 Economical
    • 3.16.3 Social
    • 3.16.4 Technological
    • 3.16.5 Legal
    • 3.16.6 Environmental

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Animal Healthcare Market, By Product

  • 5.1 Key segment trends
  • 5.2 Pharmaceuticals
    • 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.2.2 Drugs
      • 5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.2 Antiparisitic
        • 5.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.3 Anti-inflammatory
        • 5.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.4 Anti-infectives
        • 5.2.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
      • 5.2.2.5 Others
        • 5.2.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
    • 5.2.3 Vaccines
      • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.2 Modified Live Vaccines (MLV)
        • 5.2.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.3 Killed Inactivated Vaccines
        • 5.2.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.3.4 Others
        • 5.2.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.2.4 Medicated Feed Additives
      • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.2 Antibiotics
        • 5.2.4.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.3 Vitamins
        • 5.2.4.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.4 Enzymes
        • 5.2.4.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.5 Antioxidants
        • 5.2.4.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.6 Prebiotics and probiotics
        • 5.2.4.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.7 Minerals
        • 5.2.4.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
      • 5.2.4.8 Others
        • 5.2.4.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Medical devices
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.2 Veterinary Diagnostic Equipment
      • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.3 Veterinary Anesthesia Equipment
      • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.4 Veterinary Animal type Monitoring Equipment
      • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.5 Veterinary Surgical Equipment
      • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.6 Veterinary Consumables
      • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
    • 5.3.7 Others
      • 5.3.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Veterinary services
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.5 Medical devices
    • 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
  • 5.6 Veterinary services
    • 5.6.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Animal Healthcare Market, By Animal type

  • 6.1 Key segment trends
  • 6.2 Livestock animals
    • 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.2 Poultry
      • 6.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.3 Swine
      • 6.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.4 Cattle
      • 6.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.5 Fish
      • 6.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.2.6 Others
      • 6.2.6.1 Market size, by region, 2018 - 2032 (USD Million)
  • 6.3 Companion animals
    • 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.2 Dogs
      • 6.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.3 Cats
      • 6.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.4 Horses
      • 6.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
    • 6.3.5 Others
      • 6.3.5.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Animal Healthcare Market, By Distribution Channel

  • 7.1 Key segment trends
  • 7.2 Pharmacies
    • 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.3 E-commerce
    • 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
  • 7.4 Distributors
    • 7.4.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Animal Healthcare Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Poland
    • 8.3.7 The Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Taiwan
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 GCC Countries
    • 8.6.3 Israel

Chapter 9 Company Profiles

  • 9.1 Boehringer Ingelheim International GmbH
  • 9.2 Ceva Sante Animale
  • 9.3 Dechra Pharmaceuticals
  • 9.4 Elanco Animal Health
  • 9.5 Merck & Co
  • 9.6 Symrise
  • 9.7 Vetoquinol SA
  • 9.8 Virbac SA
  • 9.9 Zoetis, Inc.
  • 9.10 Medtronic plc
  • 9.11 IDEXX Laboratories
  • 9.12 HIPRA
  • 9.13 Endovac Animal Health
  • 9.14 B. Braun Vet Care (B Braun Melsungen AG)
  • 9.15 Sklar Surgical Instruments
  • 9.16 Neogen Corporation